GSK3B and cervical cancer: Some studies also indicated that SC66 effectively inhibited the phosphorylation levels of AKT through disruption of mTOR signaling, and therefore contributes to decrease the expressions of p-GSK-3β and p-FOXO1 in human cervical cancer [6].